Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening. 2019

Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.

BACKGROUND To identify the performance of fetal Down syndrome (DS) screening for developing countries. METHODS A prospective study on MSS (maternal serum screening) with complete follow-ups (n = 41,924) was conducted in 32 network hospitals in the northern part of Thailand. Various models of MSS were tested for performance. RESULTS MSS based on Caucasian reference range resulted in very high false positive rate (FPR; 13%) in our country, compared to the rate of 7.8% with our own (Thai) reference range, whereas the detection rate was comparable. As individual screening, C-S (contingent first trimester screening including PAPP-A, and free beta-hCG, classified as a) high risk [> 1:30], indicated for invasive diagnosis; b) intermediate risk [1:30-1500], indicated for STS; and c) low risk [< 1:1500], need no further tests.) was the most effective model (sensitivity 84.9%, FPR 7.7%) but nearly one-third needed the second trimester test (STS) because of intermediate results. Additionally, about one-third had their first visits in the second trimester and had no chance of FTS (first trimester screening). C-S plus STS had a sensitivity of 82.4% and FPR 8.1% whereas independent first and second trimester screening model (I-S) gave the sensitivity of 78.4% and FPR of 7.5% but was much more convenient and practical. CONCLUSIONS C-S plus STS was the most effective models while I-S model was also effective and may be better for developing countries because of its simplicity and feasibility.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003906 Developing Countries Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. LMICs,Less-Developed Countries,Low Income Countries,Low and Middle Income Countries,Lower-Middle-Income Country,Middle Income Countries,Third-World Countries,Under-Developed Countries,Developing Nations,Least Developed Countries,Less-Developed Nations,Third-World Nations,Under-Developed Nations,Countries, Middle Income,Countries, Third-World,Country, Least Developed,Country, Less-Developed,Country, Low Income,Country, Lower-Middle-Income,Country, Middle Income,Country, Third-World,Country, Under-Developed,Developed Country, Least,Developing Country,Developing Nation,Least Developed Country,Less Developed Countries,Less Developed Nations,Less-Developed Country,Less-Developed Nation,Low Income Country,Lower Middle Income Country,Lower-Middle-Income Countries,Middle Income Country,Nation, Less-Developed,Nation, Third-World,Nation, Under-Developed,Third World Countries,Third World Nations,Third-World Country,Third-World Nation,Under Developed Countries,Under Developed Nations,Under-Developed Country,Under-Developed Nation
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013785 Thailand Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city. Kingdom of Thailand,Siam
D062145 Maternal Serum Screening Tests Analysis of the level of specific BIOMARKERS in a pregnant woman's sera to identify those at risk for PREGNANCY COMPLICATIONS or BIRTH DEFECTS. Maternal Serum Triple Test

Related Publications

Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
November 2019, BMC health services research,
Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
December 1996, Clinical obstetrics and gynecology,
Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
January 1996, Prenatal diagnosis,
Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
October 1997, Ugeskrift for laeger,
Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
December 1996, Clinical obstetrics and gynecology,
Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
March 1995, Nihon Sanka Fujinka Gakkai zasshi,
Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
January 1990, Clinical genetics,
Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
November 1992, Prenatal diagnosis,
Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
May 1999, Prenatal diagnosis,
Chanane Wanapirak, and Wirawit Piyamongkol, and Supatra Sirichotiyakul, and Fuanglada Tongprasert, and Kasemsri Srisupundit, and Suchaya Luewan, and Kuntharee Traisrisilp, and Phudit Jatavan, and Theera Tongsong
December 1993, American journal of obstetrics and gynecology,
Copied contents to your clipboard!